Why the study?
Do oral contraceptives increase the risk of venous thrombosis and cardiovascular events in women?
Do oral contraceptives increase the risk of venous thrombosis and cardiovascular events in women?
Historical observations and epidemiologic studies have linked oral contraceptive use to increased risks of venous thrombosis and cardiovascular events, prompting the development of lower-estrogen formulations.
Answers are grounded in this paper and cite their sources.
Supports thrombotic caution with oral contraceptives; leaves open cardiovascular safety of current low-estrogen formulations.
In the early 1960s, shortly after the introduction of oral contraceptives, the first case reports appeared describing venous thrombosis and pulmonary emboli in women using this method of birth control. Later, myocardial infarction and stroke were also found to be associated with the use of oral contraceptives. These observations led to numerous epidemiologic and clinical studies of oral-contraceptive pills and thrombosis and subsequently to the development of new oral contraceptives with a lower estrogen content. These lower-estrogen contraceptives were considered safer: changes in hemostatic factors remained small, inconsistent in direction, and mostly within the normal range.14 Recent studies have . . .
No takes yet. Share an insight, caveat, or question.
Vandenbroucke et al. (2001) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: